Kusajili – Clinical trials directory

Result of your search per sponsor: Ipsen Pharma (UK)

Woman Max 99 years
Ipsen Pharma (UK) Update Il y a 4 ans

A prospective single-centre single-arm open-label study of the long-term use of a LHRH agonist (Decapeptyl SR 11.25mg) in combination with livial add-back therapy in the management of chronic cyclical pelvic pain in pre-menopausal women Background and study aims Decapeptyl is a synthetic (man-made) hormone that stops the ovaries producing the hormone oestrogen. It can be used to treat disorders that are dependent on oestrogen being ...

Country None
organs None
Specialty None

Closed trial

More information